T2DM drugs may cause Miscarriage: Acarbose, the widely used drug in the treatment of T2DM, may cause early pregnancy loss and fetal growth restriction via up regulation of its target gene, 22/March/2015, 23.30

Anti-metastasis therapy: MiRNA Let-7 suppresses the expression of actin-regulatory proteins FHOD1 and PPM1F and inhibits migration and invasion of metastatic cancer cells via up regulation of its target gene, 22/March/2015, 23.05
March 22, 2015
Natural product-based Life-span extension therapy: AP-2α inhibits senescence and extends life span by down regulating the expression of adenylate cyclase 5 (ADCY5), 22/March/2014, 23.36
March 22, 2015
Show all

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Web: http://genomediscovery.org

Significance:  This study suggests, for the first time, that Acarbose, by increasing the expression of its target gene, it may cause early pregnancy loss and fetal growth restriction. Thus, physicians may take this finding into consideration while prescribing acarbose to pregnant TIIDM patients. 

CitationBoominathan, T2DM drugs may cause Miscarriage: Acarbose, the widely used drug in the treatment of T2DM,  may cause early pregnancy loss and fetal growth restriction via up regulation of its target gene, 22/March/2015,  23.30, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Web: http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

Undisclosed information: How Acarbose causes early pregnancy loss and fetal growth restriction

* Research cooperation

Comments are closed.